myelogenous leukemia

myelogenous leukemia or myelogenic leukemia

n.

Leukemia characterized by proliferation of myeloid tissue in areas such as bone marrow and the spleen and by the abnormal increase of granulocytes, myelocytes, and myeloblasts in tissues and in blood. Also called granulocytic leukemia, myelocytic leukemia, myeloid leukemia.

---

myelogenous leukemia.

See myelocytic leukemia.

---

leukemia (lookē´mē),

n a usually fatal disease of the blood-forming tissues characterized by the abnormal proliferation of leukocytes and their precursors and attended by fatigue, weakness, fever, lymphadenopathy, splenomegaly, and a tendency toward profuse tissue hemorrhage. Oral lesions include gingival enlargement, severe gingivitis, and necrosis. Lymphatic, monocytic, and myelogenous leukemias are the main types.

Leukemia.

leukemia, aleukemia

(ā´lookē´mē),
n a phase of the leukemic state marked by proliferation of leukocytes within the blood-forming tissues but without an increase in the white blood cell count: relatively few precursor cells are found in the blood smear until the phase passes and the blood becomes flooded with white cells. Oral lesions, when present, are ulceronecrotic and hypertrophic.

leukemia, lymphatic (lymphoid leukemia),

n a hyperplasia, of undetermined origin, affecting lymphoid tissue. Predominating cells are lymphocytes and lymphoblasts. Generally assumes a more chronic course than other forms of leukemia but may be acute. Oral lesions include swollen and hyperplastic gingivae, ulceronecrotic lesions, and marked tendency to gingival hemorrhage.

leukemia, monocytic,

n a form characterized by an abnormal increase in the number of monocytes. Manifestations include progressive weakness, anorexia, lymphadenopathy, hepatomegaly, splenomegaly, and secondary anemia. Oral lesions may be ulceronecrotic or hemorrhagic.

leukemia, myelogenous,

n a form in which the leukocytes are of bone marrow origin (e.g., polymorphonuclear leukocytes, myelocytes, myeloblasts). Oral manifestations may include gingival enlargement, hemorrhage, and necrosis.

---

Patient discussion about myelogenous leukemia.

Q. Are there any specific treatments for acute myeloid leukemia caused by myelofibrosis? My husband was diagnosed with these conditions. His oncologist believes his AML was caused by his myelofibrosis. (scarring of the bone marrow) This was shown on his bone marrow biopsy. Myelofibrosis is a myeloproliferative disorder. Meaning certain blood components, such as WBCs, RBCs, platelets increase significantly in the marrow.

A. Thanks for taking the time to reply to me. I'll see about inquiring his oncologists.
Lynda